Contents & References of Investigating the increase of micro RNA 21 (miR-21) in the serum of patients with gastric adenocarcinoma
List:
Hypotheses.. 9
Abstract .. 11
Chapter One: General Research
1-1- Introduction .. 12
1-1- Familiarity with cancer .. 14
1-2- Stomach cancer .. 15
1-2-1- Signs and symptoms of cancer Stomach 15
1-2-2- Causes of stomach cancer. 17
1-2-3- Geographical distribution of stomach cancer in the world and Iran. 19
1-2-4- Mortality.. 21
1-2-5- Determining the stages of the disease.. 22
1-2-6- Clinical course of the disease.. 24
1-2-7- Relationship between stomach cancer and micro RNA. 25
Chapter Two: An overview of the research done. 31
Chapter Three: Materials and Methods
3-1-1 Introduction Real Time PCR. 34
3-1-2 Types of Real-Time PCR techniques. 35
3-1-3 Quantitative analyzes in Real time PCR. 36
3-1-4 Benefits of Sybr Green Real Time PCR. 36
3-1-5 Melting curve.. 37
3-1-6 Terms in Real time PCR. 38
3-2 working method.. 38
3-2-1 first step: patient selection. 39
3-2-2 Second step: preparing serum from the patient. 39
3-2-3 The third step: RNA extraction from serum. 39
3-2-4 Preparation of necessary solutions for RNA extraction kit from serum. 40
3-2-5 Evaluation of efficiency and quality of isolated RNA. 41
3-2-6 reverse transcription reaction. 43
3-2-7 Real Time PCR reaction. 44
3-2-8 Determining the base signal.. 54
3-2-8 Determining the threshold cycle.. 54
3-2-8 Melting curve analysis.. 46
3-3-1 Calculation of the amount of miRNA-21 of the samples under study. 47
3-3-2 Statistical analysis of data.. 48
Chapter Four: Results
4-1 Characteristics of patients and their pathological characteristics. 49
4-2 miRNA-21 marker expression status and its relationship with pathological factors. 50
Chapter Five: Discussion and Conclusion
5-1- Discussion .. 55
5-2- Conclusion .. 61
Sources .. 62
English abstract
Source:
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 4;144(5):646-74
Gunderson LL, Donohue JH, Alberts SR. Cancer of the Stomach. In: Abeloff MD,
Armitage JO, Lichter AS, Niederhuber JE. Kastan MB, McKenna WG, eds. Abeloff's
Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier; 2008:1431–1464.
American Cancer Society. Cancer Facts & Figures 2014. Atlanta, Ga: American Cancer Society; 2014.
Avital I, Pisters PWT, Kelsen DP, Willett CG. Cancer of the stomach, In: DeVita VT,
Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins;
2011.
Bae J, Lee E, Guyatt G. Citrus fruit intake and stomach cancer risk: A quantitative systematic review. Gastric Cancer. 2008;11:23–32
Capelle LG, de Vries AC, Looman CW, et al. Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer. 2008;44:2470–247
Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu
M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds).
SEER Cancer Statistics Review, 1975-2011.
Kappas AM, Roukos DH. Quality of surgery determinant for the outcome of patients with gastric cancer. Ann Surg Oncol. 2002;9:828–830.
Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label, randomized controlled trial. Lancet. 2008;372:392–397.
Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base report on poor survival of U.S. gastric cancer patients treated with gastrectomy. Cancer. 2008;88:921–
932.
Fuchs CS, Tomasek J, Yong CJ, et al. Ramucirumab monotherapy for previously treated advanced gastric or. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomized, multicentre, placebo-controlled, phase 3 trial. Lancet. 2014
4;383(9911):31-9.
Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362:305–315.
Hajiani E, Sarmast Sh, Mohammad H, Masjedizadeh R, Hashemi J, Azmi M, and et al.
Clinical profile of gastric cancer in Khuzestan, southwest of Iran. World J Gastroenterol
2006;12:4832-5.
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and Yan M: microRNA?21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 27: 1019?1026, 2012.
Cech TR. Crawling out of the RNA world. Cell. 2009, 136:599-602.
Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer
Lett. 2009 28;285(2):116-26.
Babashah S, Soleimani M. The oncogenic and tumor suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer. 2011;47(8):1127-37.
Wiemer EA. The role of microRNAs in cancer: no mall matter. Eur J Cancer. 2007;43(10):1529-44.
Kanellopoulou C, Monticelli S. A role for microRNAs in the development of the immune system and in the pathogenesis of cancer. Semin Cancer Biol. 2008 ;18(2):79-88.
Büssing I, Slack FJ, Grosshans H. let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 2008;14(9):9-400.
Cho WC. MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol. 2010;42(8):1273-81.
Giovannetti E, Erozenci A, Smit J, Danesi R, Peters GJ. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice. Crit Rev Oncol
Hematol. 2011 4. 1529-44.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 4;144(5):646-74.
Lim, Li J, Ding X, He M, Chang SY. microRNA and Cancer. AAPS J. 2010;12(3):309-17.
Negrini M, Nicoloso MS, Calin G. MicroRNAs and cancer - new paradigms in molecular oncology. Curr Opin Cell Biol. 2009;21(3):470-9.
H.S. El Mubarakab, R.L. De Swarta, A.D.M.E. Osterhausa, M. Schuena; Development of a semi-quantave real-timeRT-PCR for the detection of measles virus; Journal of clinical virology 317-313(2005)32.
Kimberly B. Hummel, Luis Lowe, William J. Bellini, Paul A. Rota; Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens; Journal of Virological Methods 173–166 (2006) 132.
Bok-Soon Mina, b, Yoon-Ju Noha, Jin-Ho Shin c, Sun-Young Baeka, Kyung-Il Mina, Seung-Rel Ryua, Byoung-Guk Kima, Mi-Kyung Park a, Seung-Eun Choi a, Eun-Hee Yang a, Sue-Nie Park a, Sook-Jin Hura, Byung-Yoon. Ahnb, Assessment of the quantitative real-me polymerase chain reaction using a cDNA standard for human group A rotavirus; Journal of Virological Methods 286–280 (2006) 137.
Miho Akiyama, Hirokazu Kimura, Hiroyuki Tsukagoshi, Katsuya Taira, Katsumi Mizuta, Mika Saitoh, Manami Nagano; Development of an assay for the detection and quantification of the measles virus nucleoprotein (N) gene using real-time reverse transcriptase PCR; Journal of Medical Microbiology, 2009 (643-638 58).
M. Tevfik Dorak P. Real-Time PCR. Advanced Methods ISBN -7734-4153-0X & ISBN 2007 -0-978: 13 77348-4153.
Espy MJ, Uhl JR, Sloan M, Buckwalter SP, Jones MF, Vetter JDC, et al. Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing. Clin Microbiol Rev 2006; 19(1): 165-256.
Mousavi, S. M., Gouya, M. M, Ramazani, R., Davanlou, M., Hajsadeghi, N., & Seddighi, Z. 2009. Cancer incidence and mortality in Iran. Annals of Oncology, 20(3), 556-563.
Malekzadeh R, Sotoudeh M, and et al.